Quarterly report pursuant to Section 13 or 15(d)

Nature of Business and Significant Accounting Policies - Schedule of Common Control and Ownership Interest (Details)

v3.20.2
Nature of Business and Significant Accounting Policies - Schedule of Common Control and Ownership Interest (Details)
 6 Months Ended
Jun. 30, 2020
Name of Entity One World Pharma, Inc.
One World Pharma, Inc [Member]  
Name of Entity One World Pharma, Inc [1]
State of Incorporation NV [1]
Relationship Parent [1]
OWP Ventures, Inc. [Member]  
Name of Entity OWP Ventures, Inc. [2]
State of Incorporation DE [2]
Relationship Subsidiary [2]
One World Pharma S.A.S. [Member]  
Name of Entity One World Pharma S.A.S. [3]
State of Incorporation CO [3]
Relationship Subsidiary [3]
Colombian Hope, S.A.S. [Member]  
Name of Entity Colombian Hope, S.A.S [4]
State of Incorporation CO [4]
Relationship Subsidiary [4]
[1] Holding company in the form of a corporation.
[2] Holding company in the form of a corporation and wholly-owned subsidiary of One World Pharma, Inc.
[3] Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogota on July 18, 2017. Its headquarters are located in Bogota.
[4] Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any income or expenses.